Company intelligence / Profile preview

Paysign

Henderson, Nevada, United Statespaysign.com ↗

Ownership: Public · PAYS
Employees: ~150
Development stage: Commercial

Overview

Paysign delivers commercial-stage fintech solutions focused on healthcare and pharmaceutical markets. Its patient affordability suite—including copay assistance programs—has supported over $600 million in prescription fulfillment expenses for more than 500,000 patients in the past year alone. The company’s proprietary dynamic business rules feature mitigates the impact of copay maximizers with industry-leading accuracy. In plasma donation markets, its acquisition of Gamma Innovation LLC added AI-driven donor engagement tools to further streamline operations and improve retention.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Leading pharmaceutical manufacturers/services companies

Financials

Market cap: $720.1M
Total revenue: $28.3M
Enterprise value: $698.4M

Beyond the preview

Go deeper on Paysign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paysign.

Explore the full profile